These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9573798)

  • 1. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
    Kohler JJ; Pathangey LB; Brown TA
    Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
    Kohler JJ; Pathangey LB; Gillespie SR; Brown TA
    Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.
    Dusek DM; Progulske-Fox A; Brown TA
    Infect Immun; 1994 May; 62(5):1652-7. PubMed ID: 8168925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.
    Kohler JJ; Pathangey L; Hasona A; Progulske-Fox A; Brown TA
    Infect Immun; 2000 Jul; 68(7):4370-3. PubMed ID: 10858264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
    Yang QB; Martin M; Michalek SM; Katz J
    Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
    Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
    Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
    Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.
    Kozarov E; Miyashita N; Burks J; Cerveny K; Brown TA; McArthur WP; Progulske-Fox A
    Infect Immun; 2000 Feb; 68(2):732-9. PubMed ID: 10639440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
    Pathangey L; Kohler JJ; Isoda R; Brown TA
    Vaccine; 2009 May; 27(20):2707-11. PubMed ID: 19428883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
    Katz J; Black KP; Michalek SM
    Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
    Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and immunogenicity of a cloned Porphyromonas gingivalis hemagglutinin in Salmonella typhimurium.
    Dusek DM; Progulske-Fox A; Brown TA
    Adv Exp Med Biol; 1995; 371B():1119-21. PubMed ID: 7502765
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
    Zhang P; Lewis JP; Michalek SM; Katz J
    Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis.
    Zhang P; Martin M; Yang QB; Michalek SM; Katz J
    Infect Immun; 2004 Feb; 72(2):637-44. PubMed ID: 14742503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.
    Jespersgaard C; Zhang P; Hajishengallis G; Russell MW; Michalek SM
    Infect Immun; 2001 Nov; 69(11):6604-11. PubMed ID: 11598028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
    Zhang P; Yang QB; Balkovetz DF; Lewis JP; Clements JD; Michalek SM; Katz J
    Vaccine; 2005 Sep; 23(39):4734-44. PubMed ID: 15955601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.